Vitamin D May Reduce Immune Checkpoint Inhibitor–Related Colitis
Vitamin D may be used to reduce the risk of immune checkpoint inhibitor-related colitis, as well as ulcerative colitis and graft-vs-host disease.
Side-Effect Management
Exercise, Supportive Care Are Key to Managing Cancer-Related Fatigue in Patients With Cancer
Research findings from ESMO confirm that patients with cancer can improve their symptoms of CRF if they “avoid inactivity”; in addition, greater use of supportive care can also help.
Study Finds Vancomycin Increased Risk for Cytomegalovirus Reactivation After Hematopoietic Cell Transplant
A retrospective study of CMV-seropositive adults receiving allogeneic HCT and CMV-seronegative HLA-matched sibling donors found that vancomycin exposure before HCT increased the risk for CMV reactivation.
New ASCO Clinical Guidelines on Management of Cancer Cachexia
The American Society of Clinical Oncology published new clinical guidelines on the management of cachexia in adults with advanced cancer.
Vitamin D May Cut Colitis Risk for Immune Checkpoint Inhibitors
Odds of developing ICI colitis significantly reduced with vitamin D use in patients with melanoma.
Lymphedema Control And Swelling Improved After Pneumatic Compression Therapy
Although APCD use improved lymphedema and facial swelling, participants in the treatment group reported no change in pain levels from baseline.
Genetic Polymorphisms: Understanding Their Relationship With Pain and Treatment in Patients With Cancer
A discussion on the genetic influence of single nucleotide polymorphisms on cancer pain and their potential to assist pain management in patients with cancer.
Study Shows That Control of Acute-Phase, Delayed-Phase Chemotherapy-Induced Vomiting in Pediatric Patients Is Poor
The level of control of acute-phase CIV in pediatric patients was lower in this study than has been reported for adult patients; control of delayed-phase CIV is also poor.
Are Adverse Events More Common After Radiotherapy With Immunotherapy?
Researchers aimed to determine whether the addition of radiotherapy was associated with a risk for adverse events among patients treated with ICIs.
Understanding Patient Needs May Increase Treatment Rates in AML
Physicians noted that patients receiving best supportive care were more likely to be interested in low-intensity treatments if the risk for side effects was lower.
-
Loading...
-
Loading...
